IWB provides institutional-grade exposure to the Russell 1000, leveraging high operating leverage to maintain stable margins through market-linked AUM growth. While the fund benefits from a zero-capex operational model, investors should monitor the increasing ...
Price trend, volume and key moving averages
Recent results and news deserve attention only when they alter the forward view.
Inheriting 31 stocks you never chose and barely recognize sounds like a windfall, but at 64 it can feel more like homework you never signed up for. A stepped-up cost basis changes the math on selling, and three broad funds could turn that portfolio into something you can actually manage.
Carnegie Investment Counsel acquired a new position in iShares Russell 1000 ETF (NYSEARCA:IWB) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,322 shares of the company's stock, valued at approximately $966,000. Several other institutional investors and hedge
Aspiriant LLC acquired a new position in shares of iShares Russell 1000 ETF (NYSEARCA:IWB) during the undefined quarter, according to its most recent 13F filing with the SEC. The fund acquired 121,257 shares of the company's stock, valued at approximately $50,459,000. iShares Russell 1000 ETF comprises 1.2% of Aspiriant LLC's investment portfolio,
The iShares Russell 1000 ETF (IWB) was launched on May 15, 2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the US equity market.
Get notified when IWB posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.